MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-50-0037717
Jamrex Biotech Private Limited - pharma in Lucknow, Uttar Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹3.8 Cr
▲ 47% YoY
Net profit · FY 2025
₹11.27 Lakh
Net margin 3%
EBITDA · FY 2025
₹23.14 Lakh
EBITDA margin 6.1%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹1.22 Cr
Secured borrowings
Company age
8 yrs
Est. 2018
Directors on board
3
As per MCA filings
About Jamrex Biotech Private Limited
Data last updated:
Jamrex Biotech Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 05 December 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U85190UP2018PTC110916. Its GSTIN is 09AAECJ4104B1Z4 (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Mohd Atahafeez and Mohammad Anzar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 129 Lakarmandi Baboowali Gali Daliganj, Lucknow, Uttar Pradesh, India – 226020.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.8 Cr, a growth of 47% compared to the previous year. For the same year it recorded a net profit of ₹11.27 Lakh (net margin 3%) and EBITDA of ₹23.14 Lakh (EBITDA margin 6.1%). Revenue has grown at a compounded annual rate (CAGR) of 23% over three years and 27% over five years.
The company is associated with 1 brand: Jamrex Biotech. As per MCA filings, the company has open charges of ₹1.22 Cr on record.
Jamrex Biotech Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-50-0037717). For more details, the company can be reached via its website jamrexbiotech.com.
Company details
CIN U85190UP2018PTC110916
Registration Number 110916
Incorporation Date 05 December 2018
ROC Uttar Pradesh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-UP-50-0037717
Recognitions & Rankings of Jamrex Biotech
Contact details
Jamrex Biotech Private Limited's registered office is in Lucknow, Uttar Pradesh. Its website is jamrexbiotech.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address129 Lakarmandi Baboowali Gali Daliganj, Lucknow, Uttar Pradesh, India – 226020
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Jamrex Biotech Private Limited, buy the company report.
Comprehensive company report
Jamrex Biotech Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Jamrex Biotech operates one associated brand: Jamrex Biotech. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing and distribution of formulations in healthcare. | jamrexbiotech.com |
Business activity
The main business activity of Jamrex Biotech is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Jamrex Biotech Private Limited, buy the company report.
Financials of Jamrex Biotech Private Limited
FY 2025 filings availableJamrex Biotech Private Limited reported revenue of ₹3.8 Cr (up 47% YoY) for FY 2025.
Revenue · FY 2025
₹3.8 Cr ▲ 47%
Net profit · FY 2025
₹11.27 Lakh margin 3%
EBITDA · FY 2025
₹23.14 Lakh margin 6.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 47%
3 years · compounded
▲ 23%
5 years · compounded
▲ 27%
EBITDA CAGR growth
1 year
▲ 19%
3 years · compounded
▲ 17%
5 years · compounded
▲ 71%
Revenue has grown at a compounded annual rate (CAGR) of 27% over five years, including 47% growth in the latest year. EBITDA rose 19% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹23.14 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹11.27 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.1% | ||||
| Net Profit Margin | 3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Jamrex Biotech Private Limited, buy the company report.
Board of directors of Jamrex Biotech Private Limited
Jamrex Biotech has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mohd Atahafeez | Director | 05 Dec 2018 | 7 Years 11 Months | Current |
| Mohammad Anzar | Director | 04 Jun 2025 | 1 Years 5 Months | Current |
| Ravindra Pratap Singh | Director | 05 Dec 2018 | 7 Years 11 Months | Current |
Peer comparison
Jamrex Biotech Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Seven Elife Energies System Private Limited | ₹3.81 Cr (FY 2023) | 16.0% | Jabalpur, Madhya Pradesh, India | |||
| Jai Matadi Solution Private Limited | ₹3.81 Cr (FY 2025) | 188.0% | Bhojpur, Bihar, India | |||
| Agrisan Chemicals Private Limited | ₹3.81 Cr (FY 2025) | -24.0% | Kupwad, Maharashtra, India | |||
| Senal Exports Private Limited | ₹3.8 Cr (FY 2025) | -24.0% | Ahmedabad, Gujarat, India | |||
| Premier Canvas Company Private Limited | ₹3.8 Cr (FY 2025) | 2.0% | Kolkata, West Bengal, India | |||
| Jamrex Biotech Private Limitedthis company | ₹3.8 Cr (FY 2025) | ₹11.27 Lakh | 3% | 47.0% | Lucknow, Uttar Pradesh, India | |
| Nextplus Polymers Private Limited | ₹3.8 Cr (FY 2024) | 35.0% | Mumbai, Maharashtra, India | |||
| T. P. Traders Pvt. Ltd. | ₹3.8 Cr (FY 2024) | -26.0% | Kolkata, West Bengal, India | |||
| Ridge-Wood Constructions Limited | ₹3.8 Cr (FY 2024) | 15.0% | New Delhi, Delhi, India | |||
| Papli Tex Private Limited | ₹3.8 Cr (FY 2024) | Bhilwara, Rajasthan, India | ||||
| Revastom India Private Limited | ₹3.8 Cr (FY 2024) | -3.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Jamrex Biotech Private Limited, buy the company report.
Auditor
Jamrex Biotech Private Limited is audited by PANKAJ TAYAL & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PANKAJ TAYAL & ASSOCIATES | FY 2021 | 011377C |
Shareholding
The shareholding of Jamrex Biotech Private Limited is on record for FY 2020, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2020 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Jamrex Biotech Private Limited, buy the company report.
Charges & borrowings
Open charges
₹1.22 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Dec 2025 | 101206837 | Others | ₹88 Lakh | Open | |
| 20 Nov 2025 | 101214390 | Hdfc Bank Limited | ₹15.43 Lakh | Open | |
| 27 Feb 2021 | 100437338 | Hdfc Bank Limited | ₹18.12 Lakh | Open |
Total charge records: 3 View all charges
Legal cases
No court or tribunal cases involving Jamrex Biotech Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Jamrex Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Jamrex Biotech has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAECJ4104B1Z4 | Uttar Pradesh | Active | 12 Apr 2019 |
To see the full GST registrations and return filing status of Jamrex Biotech Private Limited, buy the company report.
Recent activity
Jamrex Biotech Private Limited has 5 board changes on record since 2018: 3 appointments and 2 cessations. The latest: Horairajilani Khan ceased to be Director on 04 Jun 2025.
Charges
A charge with Others amounted to Rs. 88.00 Lakh with Charge ID 101206837 was registered on 30 Dec 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 15.43 Lakh with Charge ID 101214390 was registered on 20 Nov 2025.
AGM
Jamrex Biotech Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Horairajilani Khan ceased to be Director.
Appointed
Mohammad Anzar was appointed as Director.
Filing
Jamrex Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttar Pradesh I.
Ceased
Mohammad Anzar ceased to be Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 18.12 Lakh with Charge ID 100437338 was registered on 27 Feb 2021.
Appointed
Mohd Atahafeez was appointed as Director.
Appointed
Ravindra Pratap Singh was appointed as Director.
Incorporation
05 Dec 2018
Jamrex Biotech Private Limited was registered on 05 Dec 2018 with Roc Uttar Pradesh I & aged 7 years 11 months as per MCA records.
Frequently asked questions
Jamrex Biotech is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 05 December 2018 (8+ years old) and is registered under CIN U85190UP2018PTC110916.
Jamrex Biotech has 3 current directors:
- Mohd Atahafeez - Director
- Mohammad Anzar - Director
- Ravindra Pratap Singh - Director
The latest financial statements of Jamrex Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Jamrex Biotech is 09AAECJ4104B1Z4, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Jamrex Biotech is U85190UP2018PTC110916. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Jamrex Biotech was incorporated on 05 December 2018, making it 8+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Jamrex Biotech by revenue are Seven Elife Energies System Private Limited, Jai Matadi Solution Private Limited, Agrisan Chemicals Private Limited, Senal Exports Private Limited, Premier Canvas Company Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Horairajilani Khan ceased to be Director on 04 Jun 2025. Mohammad Anzar was appointed as Director on 04 Jun 2025. Mohammad Anzar ceased to be Director on 10 Jun 2024. Jamrex Biotech has 5 board changes on record in total.
Yes, Jamrex Biotech is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-50-0037717).
Jamrex Biotech can be reached through the website jamrexbiotech.com. Its registered office is in Lucknow, Uttar Pradesh, India.
The registered office of Jamrex Biotech is at 129 Lakarmandi Baboowali Gali Daliganj, Lucknow, Uttar Pradesh, India – 226020.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages